Attempt #70

Job: 56 • Audience: medical_affairs • Passed: True • Created: 2026-02-17 19:24:31.009693

Routing Reasons

ML fallback: low confidence (42% < 57%); The article discusses scientific and clinical aspects of Koji fungus, including biological properties, nutritional science, randomized controlled trials (RCTs), and health benefits relevant to cholesterol and immunity.; It includes detailed information on enzymatic functions, genome data, safety regulations, and emerging research findings with clinical implications, suitable for medical affairs professionals.; The content bridges scientific research and potential health applications, aligning well with medical affairs who communicate scientific evidence to healthcare professionals and support medical education.

One-line Summary

Koji fungus (Aspergillus oryzae) exhibits promising cholesterol-lowering, immunomodulatory, and metabolic benefits supported by traditional use and emerging clinical and preclinical evidence.

Decision Bullets

Tags

Key Clues

Mind Map (Raw)

mindmap
  root((Koji Fungus Benefits))
    Traditional_Uses
      Miso
      Sake
      Soy Sauce
    Biological_Properties
      Enzymes
      Non-toxigenic
      Postbiotics
    Clinical_Evidence
      Cholesterol_Reduction
      Immunomodulation
      Animal_Studies
    Industrial_Applications
      Enzyme_Production
      Food_Fermentation
      Biotechnology
    Safety_Regulations
      GRAS_Status
      Contamination_Control
    Future_Research
      Large_RCTs
      Synthetic_Biology
      Functional_Foods

Evaluator Verdict

{
  "fail_reasons": [],
  "fix_instructions": [],
  "missing_sections": [],
  "pass": true,
  "support_warning": false,
  "word_count": 92
}

Raw JSON

These are the JSON payloads stored per attempt.

{
  "decision_bullets": [
    "Scientific Summary: RCTs and animal studies substantiate Koji\u2019s lipid-lowering and immunomodulatory potential driven by enzymatic and postbiotic metabolites.",
    "Evidence Gaps: Human data on immunomodulation remains limited; long-term, large-scale clinical trials are needed.",
    "Medical Insights: Koji-derived bioactive compounds may enhance nutrition and modulate metabolic pathways without clear hypertensive risks despite sodium content in products.",
    "Stakeholder Considerations: Industry must ensure strain safety, avoid aflatoxin contamination, and adhere to regulatory GRAS standards for enzyme and food applications.",
    "Next Steps: Prioritize rigorous RCTs, isolate active molecules, and explore synthetic biology for tailored nutraceuticals."
  ],
  "evaluator": {
    "fail_reasons": [],
    "fix_instructions": [],
    "missing_sections": [],
    "pass": true,
    "support_warning": false,
    "word_count": 92
  },
  "key_clues": [
    "Non-toxigenic GRAS status enzyme producer",
    "Bioactive peptides with antioxidant, antihypertensive effects",
    "RCTs show cholesterol reduction in hyperlipidemic patients",
    "Regulates gut microbiota and host immunity via postbiotics",
    "Used traditionally for fermentation in East Asian cuisine",
    "Safety reliant on absence of toxigenic Aspergillus contamination",
    "Future potential in synthetic biology and functional food development"
  ],
  "tags": [
    "Koji fungus",
    "Aspergillus oryzae",
    "cholesterol",
    "immunity",
    "metabolism",
    "fermentation",
    "functional foods",
    "postbiotics"
  ]
}
Processing request…
This can take a few seconds.